Rankings
▼
Calendar
SOLV (Solventum Corporation) Stock Financials & Earnings | Market Cap Arena
SOLV
Solventum Corporation
Mkt Cap
$12B
Healthcare
·
Medical - Care Facilities
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$8.3B
Net Income (TTM)
$1.6B
EPS (TTM)
$8.88
Free Cash Flow (TTM)
-$10M
Gross Margin
53.5%
Op. Margin
26.2%
Net Margin
18.7%
FCF Margin
-0.1%
P/S Ratio (TTM)
1.4x
P/E Ratio (TTM)
7.6x
YoY Rev Growth
+0.9%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$2.0B
$1.1B
$365M
Q2 23
$2.1B
$1.2B
$417M
Q3 23
$2.1B
$1.2B
$504M
Q4 23
$2.0B
$1.2B
$406M
Q1 24
$2.0B
$1.2B
$381M
Q2 24
$2.1B
$1.1B
$244M
Q3 24
$2.1B
$1.2B
$275M
Q4 24
$2.1B
$1.1B
$136M
Q1 25
$2.1B
$1.1B
$152M
Q2 25
$2.2B
$1.2B
$214M
Q3 25
$2.1B
$1.2B
$137M
Q4 25
$2.0B
$985M
$1.7B
marketcaparena.com
Revenue Breakdown
SOLV
Solventum Corporation
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.5x
17.9x
Q2 23
1.5x
18.8x
Q3 23
1.5x
15.7x
Q4 23
1.4x
8.8x
Q1 24
1.4x
9.2x
Q2 24
1.4x
11.2x
Q3 24
1.4x
16.5x
Q4 24
1.4x
24.8x
Q1 25
1.4x
31.3x
Q2 25
1.4x
31.3x
Q3 25
1.4x
7.8x
Q4 25
1.4x
7.6x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$509M
$444M
Q2 23
$366M
$295M
Q3 23
$493M
$427M
Q4 23
$547M
$459M
Q1 24
$442M
$340M
Q2 24
$355M
$297M
Q3 24
$169M
$76M
Q4 24
$219M
$92M
Q1 25
$29M
-$80M
Q2 25
$169M
$59M
Q3 25
$76M
-$21M
Q4 25
$95M
$32M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$65M
Q2 23
$71M
Q3 23
$66M
Q4 23
$88M
Q1 24
$102M
Q2 24
$58M
Q3 24
$93M
Q4 24
$127M
Q1 25
$109M
Q2 25
$110M
Q3 25
$97M
Q4 25
$63M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-2.3%
+1.9%
Q2 23
+0.9%
+2.7%
Q3 23
+3.2%
-1.0%
Q4 23
+3.4%
-6.9%
Q1 24
+0.2%
-0.7%
Q2 24
+0.2%
+10.7%
Q3 24
+0.4%
+15.1%
Q4 24
+1.9%
+19.0%
Q1 25
+2.7%
+17.3%
Q2 25
+3.8%
+6.0%
Q3 25
+0.7%
+8.4%
Q4 25
-3.7%
-83.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$18M
0.9%
Q2 23
$8M
0.4%
Q3 23
$6M
0.3%
Q4 23
$7M
0.3%
Q1 24
$4M
0.2%
Q2 24
$56M
2.7%
Q3 24
$27M
1.3%
Q4 24
$25M
1.2%
Q1 25
$49M
2.4%
Q2 25
$34M
1.6%
Q3 25
$0
0.0%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$195M
$577M
Q2 23
$193M
$579M
Q3 23
$180M
$525M
Q4 23
$190M
$562M
Q1 24
$195M
$596M
Q2 24
$192M
$701M
Q3 24
$189M
$701M
Q4 24
$199M
$784M
Q1 25
$193M
$769M
Q2 25
$189M
$772M
Q3 25
$183M
$780M
Q4 25
$176M
$759M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q2 23
$39M
$0
$39M
Q3 23
$500M
$0
$500M
Q4 23
$194M
$0
$194M
Q1 24
$996M
$0
$996M
Q2 24
$897M
$0
$897M
Q3 24
$772M
$0
$772M
Q4 24
$762M
$0
$762M
Q1 25
$534M
$0
$534M
Q2 25
$492M
$0
$492M
Q3 25
$1.6B
$0
$1.6B
Q4 25
$878M
$0
$878M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
173M
+0.1%
Q2 23
173M
-0.0%
Q3 23
173M
+0.0%
Q4 23
173M
+0.0%
Q1 24
173M
+0.0%
Q2 24
174M
+0.5%
Q3 24
174M
+0.2%
Q4 24
175M
+0.3%
Q1 25
175M
+0.2%
Q2 25
175M
+0.2%
Q3 25
175M
+0.1%
Q4 25
175M
-0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
—
—
FY 24
$750K
11K
FY 25
$833K
10K
marketcaparena.com